Platinum Industries Subsidiary Enters Exclusive Commercial Agreement with Korea's CAREGEN
Platinum Industries Ltd 路 Others (Uncategorized) 路 29 Sept 2026, 5:00 pm
Platinum Industries Subsidiary Enters Exclusive Commercial Agreement with Korea's CAREGEN Rivadu Lifesciences, a subsidiary of Platinum Industries Limited, entered into an exclusive Sale/Purchase Agreement on 28th Sep'26 with Korea-based CAREGEN Co., Ltd. The agreement grants Rivadu exclusive commercial rights in India for Caregen's health functional food finished products marketed under the brand name "Korglutide". Additionally, the partnership framework includes prospects for establishing local manufacturing capabilities in India. The transaction is not a related-party deal, and no equity shares or special board appointment rights are involved.
Original exchange filing (PDF)
More announcements from Platinum Industries Ltd
- Enclosed herewith transcript of Earnings call for Unaudited financial results for quarter and half year ended 30th september 2026. 路 10 Nov 2026
- Enclosed herewith Monitoring Agency Report for the quarter ended September 30, 2026. 路 05 Nov 2026
- Enclosed herewith Investor Presentation for Unaudited Financial results for Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Disclosure under Reg 30 of SEBI (LODR) for Modified Opinion on Unaudited Financial Results for Quarter and half year ended 30ths September 2026 路 05 Nov 2026
- Platinum Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Enclosed Unaudited Standalone and Consolidated Financial results for quarter and half year ended 30th september 2026. 路 05 Nov 2026
- Outcome of Board Meeting for approving Unaudited Standalone and Consolidated Financials Results for quarter and half year ended 30th September 2026. 路 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of .... 路 05 Nov 2026
